Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by JOHN VIERLING and ABBAS RANA.
JOHN VIERLING
Connection Strength
2.811
ABBAS RANA
  1. Donor Gamma-Glutamyl Transferase Is Associated With Liver Allograft Discard and Failure. Prog Transplant. 2021 06; 31(2):101-107.
    View in: PubMed
    Score: 0.192
  2. Trends in Outcomes for Marginal Allografts in Liver Transplant. JAMA Surg. 2020 Aug 05.
    View in: PubMed
    Score: 0.184
  3. Trends in Outcomes for Marginal Allografts in Liver Transplant. JAMA Surg. 2020 Aug 05.
    View in: PubMed
    Score: 0.184
  4. Aggressive utilization of liver allografts: Improved outcomes over time. Clin Transplant. 2020 07; 34(7):e13860.
    View in: PubMed
    Score: 0.182
  5. Combined Lung-Liver and Delayed Kidney Transplantation for Cystic Fibrosis Clinical Approach and Outcome: A Case Report. Transplant Proc. 2020 Nov; 52(9):2824-2826.
    View in: PubMed
    Score: 0.181
  6. Twin epidemics: Suicides and opiate overdoses are increasingly fueling our donor supply in transplantation. Clin Transplant. 2020 05; 34(5):e13849.
    View in: PubMed
    Score: 0.180
  7. A learning curve in using orphan liver allografts for transplantation. Clin Transplant. 2020 04; 34(4):e13821.
    View in: PubMed
    Score: 0.179
  8. Metabolomic biomarkers are associated with mortality in patients with cirrhosis caused by primary biliary cholangitis or primary sclerosing cholangitis. Future Sci OA. 2019 Dec 17; 6(2):FSO441.
    View in: PubMed
    Score: 0.176
  9. Most pediatric transplant centers are low volume, adult-focused, and in proximity to higher volume pediatric centers. J Pediatr Surg. 2020 Aug; 55(8):1667-1672.
    View in: PubMed
    Score: 0.175
  10. The Observer Effect in Liver Transplantation Exemplified by Unintended Consequences of Regulation and Selected Outcome Metrics. Prog Transplant. 2019 09; 29(3):291-292.
    View in: PubMed
    Score: 0.170
  11. No Gains in Long-term Survival After Liver Transplantation Over the Past Three Decades. Ann Surg. 2019 01; 269(1):20-27.
    View in: PubMed
    Score: 0.165
  12. Predicting Liver Allograft Discard: The Discard Risk Index. Transplantation. 2018 09; 102(9):1520-1529.
    View in: PubMed
    Score: 0.161
  13. Cystatin C Is a Gender-Neutral Glomerular Filtration Rate Biomarker in Patients with Cirrhosis. Dig Dis Sci. 2018 03; 63(3):665-675.
    View in: PubMed
    Score: 0.155
  14. Liver transplant length of stay (LOS) index: A novel predictive score for hospital length of stay following liver transplantation. Clin Transplant. 2017 Dec; 31(12).
    View in: PubMed
    Score: 0.153
  15. A Surge in cadaveric liver donors and a national narcotic epidemic: Is there an association? Liver Transpl. 2017 05; 23(5):698-700.
    View in: PubMed
    Score: 0.147
  16. Early Impact of MMaT-3 Policy on Liver Transplant Waitlist Outcomes for Hepatocellular Carcinoma. Transplant Direct. 2022 May; 8(5):e1313.
    View in: PubMed
    Score: 0.052
  17. Practical Consideration for Drug Monitoring of Tacrolimus in Liver Transplantation Recipients with SARS-CoV-2 Infection. Liver Transpl. 2022 01; 28(1):127-130.
    View in: PubMed
    Score: 0.050
  18. Donor and transplant candidate selection for solid organ transplantation during the COVID-19 pandemic. Am J Transplant. 2020 11; 20(11):3113-3122.
    View in: PubMed
    Score: 0.046
  19. Unique metabolomic signature associated with hepatorenal dysfunction and mortality in cirrhosis. Transl Res. 2018 05; 195:25-47.
    View in: PubMed
    Score: 0.038
  20. Twenty-Year Comparative Analysis of Patients With Autoimmune Liver Diseases on Transplant Waitlists. Clin Gastroenterol Hepatol. 2018 02; 16(2):278-287.e7.
    View in: PubMed
    Score: 0.038
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.